Nuvaring
NDC Package 76413-131-03

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Nuvaring is a medication a vaginal ring containing combination hormone medication and is used to prevent pregnancy. Marketed by Central Texas Community Health Centers, this product is identified by NDC 76413-131 and is authorized under FDA application NDA021187.

Identification & Billing

NDC Package Code
76413-131-03
Package Description
3 POUCH in 1 BOX / 21 d in 1 POUCH
Product Code
76413-131
11-Digit Billing Format
76413013103
RxNorm Crosswalk
  • RxCUI: 1367436 - etonogestrel 0.12 MG / ethinyl estradiol 0.015 MG per 24HR 3 Week Vaginal System
  • RxCUI: 1367436 - 21 DAY ethinyl estradiol 0.000625 MG/HR / etonogestrel 0.005 MG/HR Vaginal System
  • RxCUI: 1367436 - ethinyl estradiol 0.015 MG / etonogestrel 0.12 MG per 24HR 3 Week Vaginal System
  • RxCUI: 1367436 - ethinyl estradiol 15 MCG / etonogestrel 120 MCG per 24HR 3 Week Vaginal System
  • RxCUI: 1367439 - NuvaRing 0.12 MG / 0.015 MG per 24HR 3 Week Vaginal System

Clinical Specifications

Proprietary Name
Nuvaring
Dosage Form
-
Usage Information
This product is a vaginal ring containing combination hormone medication and is used to prevent pregnancy. It contains 2 hormones: a progestin (etonogestrel) and an estrogen (ethinyl estradiol). It works mainly by preventing the release of an egg (ovulation) during your menstrual cycle. It also makes vaginal fluid thicker to help prevent sperm from reaching an egg (fertilization) and changes the lining of the uterus (womb) to prevent attachment of a fertilized egg. If a fertilized egg does not attach to the uterus, it passes out of the body. Using this product does not protect you or your partner against sexually transmitted diseases (such as HIV, gonorrhea, chlamydia).

Regulatory & Marketing

Labeler Name
Central Texas Community Health Centers
FDA Application #
NDA021187
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
10-03-2001
Listing Expiration
12-31-2019
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 76413-131-03 identifies a specific commercial package of 3 pouch in 1 box / 21 d in 1 pouch of Nuvaring, labeled by Central Texas Community Health Centers. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Central Texas Community Health Centers on October 03, 2001. The current certification is valid through December 31, 2019.

What are the primary indications for this medication?

This product is a vaginal ring containing combination hormone medication and is used to prevent pregnancy. It contains 2 hormones: a progestin (etonogestrel) and an estrogen (ethinyl estradiol). It works mainly by preventing the release of an egg (ovulation) during your menstrual cycle. It also makes vaginal fluid thicker to help prevent sperm from reaching an egg (fertilization) and changes the lining of the uterus (womb) to prevent attachment of a fertilized egg. If a fertilized egg does not attach to the uterus, it passes out of the body. Using this product does not protect you or your partner against sexually transmitted diseases (such as HIV, gonorrhea, chlamydia).

How is this Central Texas Community Health Centers product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 76413013103. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
76413-131-03
11-Digit CMS (5-4-2)
76413-0131-03

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.